Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.
We do this by channelling our efforts into identifying and sharing genuine thought leadership, executive insight and market intelligence. We disseminate this knowledge through an in depth bimonthly publication; Drugs & Dealers, through our web portal and critically through world class conferences and events that break the mould with innovative formats, networking and business development opportunities. We bring deals to life.
Who benefits from Biotech and Money
C-suite executives from early stage, small, mid-cap private and public biotech companies with active drug discovery, pre-clinical and clinical research pipelines.
C-suite executives from innovative medtech, diagnostics and digital health companies looking for funding, partnerships or collaborations.
Business Development and Licensing representatives and therapeutic heads from the industry’s leading large-cap Biotech and Pharmaceutical manufacturers.
Partners from Angel networks, private equity, venture capital, corporate venture capital and institutional investors
Stakeholders from key Government grant making bodies.
Partners and stakeholders from the top percentile of global patent attorneys, law firms, consultant advisory and members of the financial services community.
Neil Darkes, Co-CEO and Co-Founder
Neil has more than 14 years of experience in the B2B media and conference industry, 10 of which within the Life Sciences sector. For the last 8 years he held the role of General Manager of the Life sciences division of a global provider of B2B events.
He has been responsible for conceptualising, business planning, launching and developing many of the industry’s most successful executive level conference brands within the biologics sector.
Neil has a strong commercial awareness of what makes for a successful idea, brand and portfolio, and how to deliver events of significant value to c-level delegates and corporate partners.
Terry brings over 8 years experience in senior management in the B2B media and conference industry, with an enviable track record of success in building highly profitable and commercially successful brands across a variety of sectors.
He has been responsible for conceptualising, launching and developing several successful large scale events, with a particular emphasis on building events and communities that cater for c-level executives. He has extensive experience in developing and maintaining high level relationships with industry CEOs, delivering ROI to partners and sponsors, as well as strong research, business development and management skills.
Ewa has over ten years of marketing and management experience, including eight years in the B2B media industry. She has significant expertise in delivering effective digital and direct marketing programmes which generate opportunities for partners and sponsors, maximise market growth and Go to market strategies. Ewa has been leading teams in the planning, development and successful execution of multi-channel campaigns and high impact marketing solutions. She has also led the development and growth of key data assets both internally and for clients. She began her career in B2C, producing strategic consumer promotional campaigns.
Ewa holds a Masters degree in Marketing Management, and the IDM Professional Diploma in Direct & Digital Marketing.
Enrique has over 10 years’ experience in commercialising executive level conferences, with a strong track record in a variety of sectors, including 3 years growing life science related events.
He has been integral to the successful launching and growing of highly successful events, and has personally managed several high profile key accounts, helping to ensure sponsors achieve maximum value from their engagement.